The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
78 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $15,611,348 in first-year total cost, median $200,644.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-X (M1)]9
- Special Emphasis Panel[ZCA1 RTRB-F (M1)]8
- Special Emphasis Panel[ZCA1 SRB-2 (M1)]8
- Special Emphasis Panel[ZCA1 SRB-J (M1)]8
- Special Emphasis Panel[ZCA1 RTRB-E (M1)]7
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE3
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE3
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH3
- CASE WESTERN RESERVE UNIVERSITY2
- GEORGETOWN UNIVERSITY2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Sh3gl2 and chemosensitivity of bladder cancer1R21CA198722-01A1 | ADAM, ROSALYN M | BOSTON CHILDREN'S HOSPITAL, MA | $282,050 | ZCA1 |
| 2016 | Development of circulating biomarker for lung cancer1R21CA198558-01A1 | HUANG, QIHONG | WISTAR INSTITUTE, PA | $266,623 | ZCA1 |
| 2016 | Oncogene Addiction Biomarkers for a KRAS Therapy1R21CA201707-01A1 | POWIS, GARTH | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $254,475 | ZCA1 |
| 2016 | Identification of the molecular mechanism of miR-211 and its target genes in melanocytes and pigmented melanoma senescence and apoptosis1R21CA202197-01A1 | PERERA, RANJAN JOSEPH | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $254,475 | ZCA1 |
| 2016 | Evaluating the Effect of the Breast Density Legislation on Supplemental Screening1R21CA209442-01 | HENDERSON, LOUISE | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $248,710 | ZCA1 |
| 2016 | Targeting Beta-Adrenergic Signaling to Control GVH and GVL Responses1R21CA202358-01A1 | CAO, XUEFANG | ROSWELL PARK CANCER INSTITUTE CORP, NY | $245,900 | ZCA1 |
| 2016 | New methods to address dilemmas in mixed recurrent-event and panel-count data1R21CA198641-01A1 | ZHU, LIANG | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $240,361 | ZCA1 |
| 2016 | Kinase Dependent Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer1R21CA209121-01 | KERN, JEFFREY A | NATIONAL JEWISH HEALTH, CO | $237,381 | ZCA1 |
| 2016 | Mechanism of Ikaros Tumor Suppression in progenitor B cell leukemia1R21CA209229-01 | FRIETZE, SETH ESCHJERVEN, HILDE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $235,196 | ZCA1 |
| 2016 | A Question Prompt List to Promote Communication in Genomic Medicine1R21CA201827-01A1 | O'NEILL, SUZANNE C. | GEORGETOWN UNIVERSITY, DC | $233,416 | ZCA1 |
| 2016 | Systematic Programmed Illumination (sPI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue During Hematopoeitic Stem Cell Transplantation for Multiple Myeloma1R21CA209419-01 | REDD, WILLIAM H | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $233,051 | ZCA1 |
| 2016 | The role of IL-27 cytokine in hepatocellular carcinoma (HCC) development1R21CA202396-01A1 | KOLTSOVA, EKATERINA | RESEARCH INST OF FOX CHASE CAN CTR, PA | $232,943 | ZCA1 |
| 2016 | Phase II Trial of Nicotinamide Riboside for Relief of Taxane-Induced Sensory Neuropathy1R21CA208968-01 | HAMMOND, DONNA LTHOMAS, ALEXANDRA | UNIVERSITY OF IOWA, IA | $232,181 | ZCA1 |
| 2016 | Prostate Specific Membrane Antigen Targeted Photoacoustic Imaging for Prostate Cancer1R21CA202199-01A1 | BOCTOR, EMAD MCHEN, YING | JOHNS HOPKINS UNIVERSITY, MD | $227,205 | ZCA1 |
| 2016 | New approaches to target protein intramolecular interactions1R21CA208363-01 | CHEN, JIANDONG | H. LEE MOFFITT CANCER CTR & RES INST, FL | $224,460 | ZCA1 |
| 2016 | Acupressure Intervention to Improve Fatigue and Physical Functioning of Chinese Immigrant Breast Cancer Survivors1R21CA209213-01 | WANG, JUDY HUEI-YU | GEORGETOWN UNIVERSITY, DC | $219,496 | ZCA1 |
| 2016 | Follow-up care and preventive service use among survivors of adolescent and young adult cancer.1R21CA198042-01A1 | CHAO, CHUN R. | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $217,666 | ZCA1 |
| 2016 | Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness1R21CA201865-01A1 | GILL, INDERBIRLIANG, GANGNING | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $215,325 | ZCA1 |
| 2016 | In vivo imaging of tumor heterogeneity generation from endogenous single cells1R21CA209012-01 | FRASER, SCOTT E | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $215,325 | ZCA1 |
| 2016 | Identifying epigenetic targets of c-myc oncogene1R21CA205172-01A1 | WU, SONGZONG, WEI-XING | RUTGERS, THE STATE UNIV OF N.J., NJ | $214,082 | ZCA1 |
| 2016 | PSGL-1, a New Player in the Immune Checkpoint Landscape1R21CA209627-01 | BRADLEY, LINDA MAC PHERSON | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $212,063 | ZCA1 |
| 2016 | Molecular Pathways of Interleukin-13 in Cutaneous T-cell Lymphoma1R21CA209107-01 | FUSCHIOTTI, PATRIZIA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $211,603 | ZCA1 |
| 2016 | CMV infection and NK-cell therapy for multiple myeloma1R21CA197527-01A1 | REZVANI, KATYSIMPSON, RICHARD J | UNIVERSITY OF HOUSTON, TX | $211,261 | ZCA1 |
| 2016 | Systemic delivery of miR-29 for basal-like breast cancer treatment1R21CA209045-01 | SHU, DANXU, REN | UNIVERSITY OF KENTUCKY, KY | $211,076 | ZCA1 |
| 2016 | Identifying the biosynthesis of a potent cytotoxic agent Lasonolide A1R21CA209189-01 | WANG, GUOJUN | FLORIDA ATLANTIC UNIVERSITY, FL | $209,674 | ZCA1 |
| 2016 | Overcoming Primary Ibrutinib Resistance in Mantle Cell Lymphoma Using Patient-Derived Models and Molecular Profiling1R21CA202104-01A1 | WANG, MICHAEL | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $208,800 | ZCA1 |
| 2016 | Assessing deformable image registration in the lung using hyperpolarized-gas MRI1R21CA195317-01A1 | CAI, JINGMILLER, G. WILSON | DUKE UNIVERSITY, NC | $207,860 | ZCA1 |
| 2016 | New mechanisms of breast cancer metastasis and loss of estrogen receptor driven by 14-3-31R21CA198041-01A1 | LIN, WEEI-CHIN | BAYLOR COLLEGE OF MEDICINE, TX | $206,843 | ZCA1 |
| 2016 | ESTABLISHING A CONDITIONAL TELOMERASE KNOCK-IN ALLELE IN A HAPLOID CANCER CELL LINE TO IDENTIFY REGULATORS OF ALT THROUGH GENETIC FORWARD SCREENS1R21CA198701-01A1 | SAHIN, ERGUN | BAYLOR COLLEGE OF MEDICINE, TX | $206,843 | ZCA1 |
| 2016 | Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL)1R21CA201775-01A1 | PARAMESWARAN, RESHMI | CASE WESTERN RESERVE UNIVERSITY, OH | $206,843 | ZCA1 |
| 2016 | Mechanisms underlying the protective effect of exercise and weight maintenance on metastatic progression in breast cancer1R21CA209144-01 | ROGERS, CONNIE J | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $205,146 | ZCA1 |
| 2016 | Identifying insulin resistance biomarkers and metabolomic signature as predictors of precursors to pancreatic cancer1R21CA209366-01 | SCHMIDT, CHRISTIAN MAXIMILLIANZHANG, JIANJUN | INDIANA UNIVERSITY INDIANAPOLIS, IN | $203,906 | ZCA1 |
| 2016 | Using the Collaborative Cross for Model Studies of Intestinal Cancer1R21CA202496-01A1 | SIRACUSA, LINDA D | THOMAS JEFFERSON UNIVERSITY, PA | $203,580 | ZCA1 |
| 2016 | A dedicated two dimensional antiscatter grid for CBCT in radiation therapy1R21CA198462-01A1 | ALTUNBAS, CEM | UNIVERSITY OF COLORADO DENVER, CO | $202,928 | ZCA1 |
| 2016 | Discovering and Characterizing Novel Pregnancy-Associated Cancers1R21CA208793-01 | CRUMP, CASEYSIEH, WEIVASUNDQUIST, KRISTINA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $202,673 | ZCA1 |
| 2016 | Structural Analysis of Cancerous Inhibitor of PP2A (CIP2A)1R21CA201944-01A1 | XU, WENQING | UNIVERSITY OF WASHINGTON, WA | $201,623 | ZCA1 |
| 2016 | Development of DNA Polymerase θ Inhibitors for Precision Medicine in BRCA Deficient Cancers1R21CA209281-01 | POMERANTZ, RICHARD T | TEMPLE UNIV OF THE COMMONWEALTH, PA | $201,144 | ZCA1 |
| 2016 | Dim light at night alters pancreatic cell signaling and predisposes to pancreatic adenocarcinoma1R21CA202745-01A1 | NELSON, RANDY J. | OHIO STATE UNIVERSITY, OH | $200,970 | ZCA1 |
| 2016 | SFK-inhibitor enhancement of ATRA-mediated differentiation of APL1R21CA201831-01A1 | REDNER, ROBERT L | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $200,970 | ZCA1 |
| 2016 | Targeting cytokine mediated CREB activation in pancreatic cancer1R21CA209536-01 | NAGATHIHALLI, NAGARAJ S. | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $200,318 | ZCA1 |
| 2016 | Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia1R21CA202488-01A1 | SWORDS, RONAN THOMAS | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $200,318 | ZCA1 |
| 2016 | Heat shock proteins and modulation of immune responses1R21CA208833-01 | BINDER, ROBERT J | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $200,030 | ZCA1 |
| 2016 | Identification of Long Non-coding RNAs as Novel Biomarkers for Heterogeneous Glioblastomas1R21CA209345-01 | CHENG, SHI-YUANZHANG, WEI | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $199,629 | ZCA1 |
| 2016 | Validation of FOXM1 as a new therapeutic target in high-risk myeloma1R21CA187388-01A1 | JANZ, SIEGFRIED | UNIVERSITY OF IOWA, IA | $199,013 | ZCA1 |
| 2016 | Re-sensitizing ER-Alpha Mutant Breast Cancer Cells to Hormonal Therapy1R21CA209154-01 | LI, RONG | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $199,013 | ZCA1 |
| 2016 | A novel oncogenic driver in Ewing sarcoma1R21CA202485-01A1 | SHIIO, YUZURU | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $199,013 | ZCA1 |
| 2016 | p16 mechanisms in melanoma1R21CA201757-01A1 | GROSSMAN, DOUGLAS | UNIVERSITY OF UTAH, UT | $197,055 | ZCA1 |
| 2016 | Recruitment of melanoma-specific CD4+ T cells1R21CA209551-01 | WILLIAMS, MATTHEW A | UNIVERSITY OF UTAH, UT | $197,055 | ZCA1 |
| 2016 | Role of TFIIS.h in regulation of p53 responsive apoptosis and tumor suppression1R21CA201889-01A1 | LU, HUA | TULANE UNIVERSITY OF LOUISIANA, LA | $196,403 | ZCA1 |
| 2016 | The role of KIF2C/AURKA signaling in cilia loss and progression of glioblastoma.1R21CA208875-01 | PUGACHEVA, ELENA NIKOLAEVNA | WEST VIRGINIA UNIVERSITY, WV | $195,750 | ZCA1 |
| 2016 | Preventing postpartum smoking relapse: a twitter-enabled supportive intervention1R21CA198036-01A1 | WEN, KUANG-YI | RESEARCH INST OF FOX CHASE CAN CTR, PA | $194,119 | ZCA1 |
| 2016 | Diet-dependent regulation of DCIS progression1R21CA197896-01A1 | PORTER, WESTON W | TEXAS A&M AGRILIFE RESEARCH, TX | $193,793 | ZCA1 |
| 2016 | Altered mitochondria-ER signaling as a cause of chemotherapy resistance1R21CA198430-01A1 | HOGARTY, MICHAEL D | CHILDREN'S HOSP OF PHILADELPHIA, PA | $193,314 | ZCA1 |
| 2016 | Biophysical and Mechanistic Determinants for Cancer Cell Import of Hydrocarbon-Stapled Peptides1R21CA209358-01 | WALENSKY, LOREN DAVID | DANA-FARBER CANCER INST, MA | $190,313 | ZCA1 |
| 2016 | High Throughput Mechanical Modulatory Assay for Breast Cancer Drug Testing1R21CA210126-01 | AGAH, MASOUD | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $186,775 | ZCA1 |
| 2016 | Targeting the glucocorticoid receptor in enzalutamide resistant prostate cancer1R21CA202122-01A1 | GARABEDIAN, MICHAEL J. | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $184,331 | ZCA1 |
| 2016 | Regulating centrosome homeostasis through the UPS1R21CA202200-01A1 | PAGANO, MICHELE | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $184,331 | ZCA1 |
| 2016 | Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer1R21CA209341-01 | FRUMAN, DAVID ALEXANDER | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $178,474 | ZCA1 |
| 2016 | Prevention of radiation-induced neurocognitive dysfunction by induced adult neural stem cell1R21CA202785-01A1 | KAI, MIHOKO | JOHNS HOPKINS UNIVERSITY, MD | $177,353 | ZCA1 |
| 2016 | Immunological manipulation of resistance to molecularly targeted inhibitors1R21CA209375-01 | TURK, MARY JO | DARTMOUTH COLLEGE, NH | $176,175 | ZCA1 |
| 2016 | Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastoma1R21CA202403-01A1 | BURMA, SANDEEP | UT SOUTHWESTERN MEDICAL CENTER, TX | $176,131 | ZCA1 |
| 2016 | Deciphering Autophagy-Dependent Secretion In Cancer Via Proximity-Based Biotinylation1R21CA201849-01A1 | DEBNATH, JAYANTA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $172,369 | ZCA1 |
| 2016 | ALK causes TGF-beta insensitivity in lung cancer cells1R21CA209007-01 | FENG, XIN-HUA | BAYLOR COLLEGE OF MEDICINE, TX | $172,369 | ZCA1 |
| 2016 | Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases1R21CA209304-01 | GREENFIELD, EDWARD M. | CASE WESTERN RESERVE UNIVERSITY, OH | $172,369 | ZCA1 |
| 2016 | MicroRNAs Modulate Therapy Resistance in Prostate Cancer1R21CA202404-01A1 | NADIMINTY, NAGALAKSHMI | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $170,738 | ZCA1 |
| 2016 | Targeting MMP-9 for breast cancer therapy (R21 CA205471 Resubmission)1R21CA205471-01A1 | RADISKY, EVETTE S | MAYO CLINIC JACKSONVILLE, FL | $170,408 | ZCA1 |
| 2016 | HSC-Independent Mechanisms Underlying JMML1R21CA202296-01A1 | CHAN, REBECCA J.YODER, MERVIN C. | INDIANA UNIVERSITY INDIANAPOLIS, IN | $169,650 | ZCA1 |
| 2016 | Using zebrafish to study the role of six1a/b and microRNA-30a in rhabdomyosarcoma (RMS) initiation and progression1R21CA201809-01A1 | ARTINGER, KRISTINFORD, HEIDE L. | UNIVERSITY OF COLORADO DENVER, CO | $169,106 | ZCA1 |
| 2016 | Trace element supplementation to enhance calcium-mediated suppression of human colon adenoma growth1R21CA201782-01A1 | VARANI, JAMES | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $168,563 | ZCA1 |
| 2016 | Inhibiting Basal Cell Carcinoma By Promoting Cellular Differentiation1R21CA209166-01 | WONG, SUNNY Y | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $168,563 | ZCA1 |
| 2016 | Neurotensin in Fibrolamellar Liver Cancer1R21CA201867-01A1 | RIEHLE, KIMBERLY J | UNIVERSITY OF WASHINGTON, WA | $168,019 | ZCA1 |
| 2016 | Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia1R21CA209183-01 | PERROTTI, DANILO | UNIVERSITY OF MARYLAND BALTIMORE, MD | $167,475 | ZCA1 |
| 2016 | Delineating roles for a novel tri-protein complex (TRIM44) in the multiple myeloma stem cell niche1R21CA202212-01A1 | MCCARTY, NAMI | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $167,475 | ZCA1 |
| 2016 | The Role of hnRNP L in Non-Small Cell Lung Cancer1R21CA201195-01A1 | PARK, MARGARET AMY | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $165,844 | ZCA1 |
| 2016 | Bifunctional ligand development for targeted Positron Emission Tomography (PET) using Zirconium-891R21CA201999-01A1 | LEWIS, JASON S. | SLOAN-KETTERING INST CAN RESEARCH, NY | $161,344 | ZCA1 |
| 2016 | PRMT1-mediated metabolic reprogramming in leukemia progression1R21CA202390-01A1 | KLUG, CHRISTOPHERZHAO, XINYANG | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $159,863 | ZCA1 |
| 2016 | Gene-Gene Interactions and Their Functional Roles in Prostate Cancer Aggressiveness1R21CA202417-01A1 | LIN, HUI-YI | LSU HEALTH SCIENCES CENTER, LA | $147,791 | ZCA1 |
| 2016 | Stem Cell-Adrenomedullin Therapy for Cancer Linked Lymphedema1R21CA201940-01A1 | HU, MICKEY C-T | STANFORD UNIVERSITY, CA | $74,569 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.